• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

墨西哥高生育力人群中卵巢癌和子宫内膜癌风险的生殖因素

Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico.

作者信息

Salazar-Martinez E, Lazcano-Ponce E C, Gonzalez Lira-Lira G, Escudero-De los Rios P, Salmeron-Castro J, Hernandez-Avila M

机构信息

Center for Research in Population Health, National Institute of Public Health, Cuernavaca, Morelos, Mexico.

出版信息

Cancer Res. 1999 Aug 1;59(15):3658-62.

PMID:10446978
Abstract

A case-control study was carried out in Mexico City during 1995-1997 among women with epithelial ovarian cancer (84 cases) and endometrial cancer (85 cases). The control group consisted of 668 healthy women, matched according to age categories. In a multivariate analysis, the reproductive risk factors for ovarian and endometrial cancer are similar. The risk of ovarian cancer was inversely related to the number of full-term pregnancies; the odds ratio (OR) was 0.17 and the 95% confidence interval (CI) was 0.05-0.54 when comparing nulliparous women versus those with more than seven pregnancies. For endometrial cancer, a similar association was observed (OR, 0.11; 95% CI, 0.04-0.34). The use of oral contraceptive hormones was inversely associated with both ovarian (OR, 0.36; 95% CI, 0.15-0.83) and endometrial cancer risk (OR, 0.36; 95% CI, 0.14-0.90). In women with a history of more than 8.7 years without ovulation, the risk of ovarian cancer decreased four times (OR, 0.23; 95% CI, 0.10-0.50), and that of endometrial cancer decreased more than five times (OR, 0.17; 95% CI, 0.08-0.35). These two neoplasms are clearly typified as hormone dependent, and it is possible to establish that "ovulation" and "exfoliative" mechanisms jointly determine the level of risk for both ovarian and endometrial cancer.

摘要

1995年至1997年期间,在墨西哥城对患有上皮性卵巢癌(84例)和子宫内膜癌(85例)的女性进行了一项病例对照研究。对照组由668名健康女性组成,根据年龄类别进行匹配。在多变量分析中,卵巢癌和子宫内膜癌的生殖风险因素相似。卵巢癌风险与足月妊娠次数呈负相关;将未生育女性与生育七次以上的女性相比,比值比(OR)为0.17,95%置信区间(CI)为0.05 - 0.54。对于子宫内膜癌,观察到类似的关联(OR,0.11;95% CI,0.04 - 0.34)。口服避孕药激素的使用与卵巢癌(OR,0.36;95% CI,0.15 - 0.83)和子宫内膜癌风险(OR,0.36;95% CI,0.14 - 0.90)均呈负相关。在无排卵病史超过8.7年的女性中,卵巢癌风险降低四倍(OR,0.23;95% CI,0.10 - 0.50),子宫内膜癌风险降低超过五倍(OR,0.17;95% CI,0.08 - 0.35)。这两种肿瘤明显被归类为激素依赖性肿瘤,并且可以确定“排卵”和“剥脱”机制共同决定了卵巢癌和子宫内膜癌的风险水平。

相似文献

1
Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico.墨西哥高生育力人群中卵巢癌和子宫内膜癌风险的生殖因素
Cancer Res. 1999 Aug 1;59(15):3658-62.
2
Risk factors for ovarian cancer in central Italy.意大利中部卵巢癌的危险因素。
Gynecol Oncol. 2000 Oct;79(1):50-4. doi: 10.1006/gyno.2000.5909.
3
Sex steroids and breast cancer prevention.性类固醇与乳腺癌预防。
J Natl Cancer Inst Monogr. 1994(16):139-47.
4
Menstrual and reproductive factors in relation to risk of endometrial cancer in Chinese women.中国女性中与子宫内膜癌风险相关的月经和生殖因素。
Cancer Causes Control. 2006 Sep;17(7):949-55. doi: 10.1007/s10552-006-0034-6.
5
Timing of pregnancy and the risk of epithelial ovarian cancer.妊娠时间与上皮性卵巢癌风险
Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):42-6.
6
Hormone replacement therapy and cancer.激素替代疗法与癌症。
Gynecol Endocrinol. 2001 Dec;15(6):453-65.
7
Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.上皮性卵巢交界性肿瘤的危险因素:一项瑞典病例对照研究的结果
Gynecol Oncol. 2001 Dec;83(3):575-85. doi: 10.1006/gyno.2001.6451.
8
Menstrual and reproductive risk factors and risk for gastric adenocarcinoma in women: findings from the canadian national enhanced cancer surveillance system.女性的月经和生殖风险因素与胃腺癌风险:来自加拿大国家强化癌症监测系统的发现
Ann Epidemiol. 2006 Dec;16(12):908-16. doi: 10.1016/j.annepidem.2006.03.001. Epub 2006 Jul 13.
9
Contraception and the big "C".避孕与癌症
Malays J Reprod Health. 1992 Jun;10(1):1-5.
10
Oral contraceptive use, reproductive factors, and colorectal cancer risk: findings from Wisconsin.口服避孕药的使用、生殖因素与结直肠癌风险:来自威斯康星州的研究结果
Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1212-8. doi: 10.1158/1055-9965.EPI-04-0845.

引用本文的文献

1
Endometrioid adenofibroma of ovary - a literature review.卵巢子宫内膜样腺纤维瘤——文献综述
Rom J Morphol Embryol. 2025 Jan-Mar;66(1):39-49. doi: 10.47162/RJME.66.1.03.
2
Association of oral contraceptives and risk of endometrial cancer: A systematic review and meta-analysis.口服避孕药与子宫内膜癌风险的关联:一项系统评价与荟萃分析。
Acta Obstet Gynecol Scand. 2025 Apr;104(4):591-603. doi: 10.1111/aogs.15043. Epub 2025 Feb 21.
3
Pre-pregnancy intrauterine device use is associated with a reduced risk of subsequent preterm birth: a large population-based cohort study.
孕前宫内节育器的使用与降低随后早产的风险相关:一项基于人群的大型队列研究。
BMC Public Health. 2025 Feb 18;25(1):670. doi: 10.1186/s12889-025-21766-9.
4
A meta-analysis of the association between adolescent pregnancy and the risk of gynecological cancers.青少年怀孕与妇科癌症风险之间关联的荟萃分析。
Epidemiol Health. 2024;46:e2024094. doi: 10.4178/epih.e2024094. Epub 2024 Nov 26.
5
The risk of ovarian cancer in hormone replacement therapy users: a systematic review and meta-analysis.激素替代疗法使用者患卵巢癌的风险:一项系统评价与荟萃分析。
Front Endocrinol (Lausanne). 2024 Jul 17;15:1414968. doi: 10.3389/fendo.2024.1414968. eCollection 2024.
6
The Use of Lipid-based Nanocarriers to Improve Ovarian Cancer Treatment: An Overview of Recent Developments.脂质纳米载体在卵巢癌治疗中的应用:最新进展概述。
Curr Pharm Biotechnol. 2024;25(17):2200-2217. doi: 10.2174/0113892010279572240126052844.
7
Deciphering the Therapeutic Applications of Nanomedicine in Ovarian Cancer Therapy: An Overview.纳米医学在卵巢癌治疗中的治疗应用解析:综述。
Curr Drug Deliv. 2024;21(9):1180-1196. doi: 10.2174/0115672018253815230922070558.
8
Racial/ethnic differences in anthropometric and hormone-related factors and endometrial cancer risk: the Multiethnic Cohort Study.种族/民族差异在人体测量和激素相关因素与子宫内膜癌风险之间的关系:多民族队列研究。
Br J Cancer. 2021 May;124(10):1724-1733. doi: 10.1038/s41416-021-01292-2. Epub 2021 Mar 15.
9
Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection.与卵巢癌相关的合并症和炎症及其对 SARS-CoV-2 感染的影响。
J Ovarian Res. 2021 Feb 25;14(1):39. doi: 10.1186/s13048-021-00787-z.
10
Racial/Ethnic Differences in Ovarian Cancer Risk: Results from the Multiethnic Cohort Study.种族/民族差异与卵巢癌风险:来自多民族队列研究的结果。
Cancer Epidemiol Biomarkers Prev. 2020 Oct;29(10):2019-2025. doi: 10.1158/1055-9965.EPI-20-0569. Epub 2020 Jul 30.